Key points are not available for this paper at this time.
Despite good evidence for its effectiveness in HIV prevention, countries such as Russia remain resistant to harm reduction. Tim Rhodes and colleagues show the obstacles to and potential benefits of changing policy on opiate substitution treatment
Rhodes et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: